Additionally, Fan et al. (73) introduced a novel strategy of combining decitabine which was able to reverse GSDME silencing with chemotherapy nanodrugs LipoDDP for causing cancer cells to activate the caspase-3 pathway and eventually stimulated the occurrence of pyroptosis. Here, CASP3 is linked to cancer.